Low Medicare Part D Enrollment Could Cause Sponsors To “Retrench” – Attorney
This article was originally published in The Pink Sheet Daily
Slow enrollment could result in “significant consolidation” within 18 to 24 months, Sonnenschein Nath & Rosenthal partner Fried says during Drug & Device Dialogue audio conference. He also suggests that the large number of applicants seeking to sponsor Part D plans resulted from a defensive business stance by potential sponsors.
You may also be interested in...
Seniors will not be overwhelmed by a high number of plan choices, the agency administrator maintains. CMS has received a large volume of Part D applications, but not all look “complete and serious,” McClellan indicates.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles